Tracie Oliver
Corporate Officer/Principal chez ARROWHEAD PHARMACEUTICALS, INC.
Fortune : 3 M $ au 30/04/2024
Profil
Tracie Oliver is the Chief Commercial Officer at Arrowhead Pharmaceuticals, Inc. She previously worked as the Head-Ortho Biotech Nephrology Business Unit at Johnson & Johnson.
She was also the Global Head-New Product Planning & Device Strategy at Shire Pharmaceuticals, Inc. from 2016 to 2017.
Ms. Oliver has an undergraduate and graduate degree from Queen's University and an MBA from The Schulich School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/01/2024 | 136 501 ( 0,11% ) | 3 M $ | 30/04/2024 |
Postes actifs de Tracie Oliver
| Sociétés | Poste | Début |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2022 |
Anciens postes connus de Tracie Oliver
| Sociétés | Poste | Fin |
|---|---|---|
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | 01/03/2017 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Formation de Tracie Oliver
| Queen's University | Graduate Degree |
| The Schulich School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| Entreprise privées | 1 |
|---|---|
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
